Interference of Hawthorn on Serum Digoxin Measurements by Immunoassays and Pharmacodynamic Interaction With Digoxin

被引:2
|
作者
Dasgupta, Amitava [1 ]
Kidd, Laura [1 ]
Poindexter, Brian J. [1 ]
Bick, Roger J. [1 ]
机构
[1] Univ Texas Med Sch, Dept Pathol & Lab Med, Houston, TX USA
关键词
HEART-FAILURE; SIBERIAN GINSENG; MEDICINE; EXTRACT;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Context.-Hawthorn is an herb indicated for treating cardiac illness. Because a patient taking digoxin may also take hawthorn, we investigated potential interference of hawthorn in serum digoxin measurements using immunoassays as well as pharmacodynamic interaction between hawthorn and digoxin. Hawthorn contains alkaloids that are structurally similar to digoxin and may interfere with serum digoxin measurement using immunoassays. In addition, hawthorn has cardioactive properties similar to digoxin. Objective.-To study potential pharmacodynamic interaction between hawthorn and digoxin. Design.-The effects of hawthorn extract on serum digoxin measurements using Digoxin III (Abbott Laboratories, Abbott Park, Illinois) and the Tina-Quant digoxin assay (Roche Diagnostics, Indianapolis, Indiana) were investigated using 2 different brands of extract. To study the pharmacodynamic interaction between hawthorn and digoxin, we used an isolated adult rat cardiomyocyte system, measuring calcium transients by real-time fluorescence spectrophotometry. Results.-Hawthorn interfered only with the Digoxin III immunoassay but had no effect on the Tina-Quant assay. Both hawthorn extracts increased intracellular calcium levels, but the lack of additive response with digoxin suggests both may bind to the same site of Na, K adenosine triphosphatase. Conclusion.-Because of interference of hawthorn with a digoxin immunoassay and pharmacodynamic interaction with digoxin, a patient receiving digoxin should avoid hawthorn. (Arch Pathol Lab Med. 2010; 134: 1188-1192)
引用
收藏
页码:1188 / 1192
页数:5
相关论文
共 50 条
  • [41] DIGOXIN TOXICITY DUE TO INTERACTION OF DIGOXIN WITH ERYTHROMYCIN
    MAXWELL, DL
    GILMOURWHITE, SK
    HALL, MR
    BRITISH MEDICAL JOURNAL, 1989, 298 (6673): : 572 - 572
  • [42] A SIMPLE METHOD TO ASSAY SERUM DIGOXIN WITH REDUCED INTERFERENCE FROM METABOLITES AND ENDOGENOUS DIGOXIN LIKE FACTORS
    LONGERICH, L
    VASDEV, S
    JOHNSON, E
    GAULT, MH
    CLINICAL CHEMISTRY, 1988, 34 (06) : 1250 - 1250
  • [43] Serum digoxin in the presence of Digibind: determination of digoxin by the Abbott AxSYM and Baxter Stratus II immunoassays by direct analysis without pretreatment of serum samples
    Ocal, IT
    Green, TR
    CLINICAL CHEMISTRY, 1998, 44 (09) : 1947 - 1950
  • [44] METHODS FOR ELIMINATING INTERFERENCES IN DIGOXIN IMMUNOASSAYS CAUSED BY DIGOXIN-LIKE FACTORS
    GRAVES, SW
    SHARMA, K
    CHANDLER, AB
    CLINICAL CHEMISTRY, 1986, 32 (08) : 1506 - 1509
  • [45] QUINIDINE-DIGOXIN INTERACTION - DO HIGH DIGOXIN CONCENTRATIONS IN THE SERUM HAVE AN EFFECT ON THE HEART
    DOERING, W
    BELZ, GG
    AUST, PE
    RIEGER, G
    KONIG, E
    ZEITSCHRIFT FUR KARDIOLOGIE, 1981, 70 (04): : 310 - 310
  • [46] EVALUATION OF THE PHARMACODYNAMIC AND PHARMACOKINETIC INTERACTION BETWEEN CALCIUM-ANTAGONISTS AND DIGOXIN
    DEVITO, JM
    FRIEDMAN, B
    PHARMACOTHERAPY, 1986, 6 (02): : 73 - 82
  • [47] TISSUE DIGOXIN CONCENTRATIONS AND DIGOXIN EFFECT DURING THE QUINIDINE-DIGOXIN INTERACTION
    WARNER, NJ
    BARNARD, JT
    BIGGER, JT
    EINSTEIN, R
    UHL, EW
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 5 (03) : 680 - 686
  • [48] ACUTE AND CHRONIC PHARMACODYNAMIC INTERACTION OF VERAPAMIL AND DIGOXIN IN ATRIAL-FIBRILLATION
    SCHWARTZ, JB
    KEEFE, D
    KATES, RE
    KIRSTEN, E
    HARRISON, DC
    CIRCULATION, 1982, 65 (06) : 1163 - 1170
  • [49] Clopidogrel, a novel antiplatelet agent, and digoxin: Absence of pharmacodynamic and pharmacokinetic interaction
    Peeters, PAM
    Crijns, HJMJ
    Tamminga, WJ
    Jonkman, JHG
    Dickinson, JP
    Necciari, J
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1999, 25 : 51 - 54
  • [50] Interference of endogenous digoxin-like immunoreactive factors in serum digoxin measurement is minimized in a new turbidimetric digoxin immunoassay on ADVIA 1650 analyzer
    Datta, P
    Dasgupta, A
    THERAPEUTIC DRUG MONITORING, 2004, 26 (01) : 85 - 89